# Assessing the Ability of the T-SPOT®.TB Test (IQ)

> **NCT03973970** · — · COMPLETED · sponsor: **Oxford Immunotec** · enrollment: 201 (actual)

## Conditions studied

- Tuberculosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03973970
- **Lead sponsor:** Oxford Immunotec
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-23
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 201 (ACTUAL)
- **Last updated:** 2021-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03973970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03973970, "Assessing the Ability of the T-SPOT®.TB Test (IQ)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03973970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*